4/A//SEC Filing
Ross Leonard S 4/A
Accession 0000899243-18-017684
CIK 0001314102other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:00 PM ET
Size
8.3 KB
Accession
0000899243-18-017684
Insider Transaction Report
Form 4/AAmended
Ross Leonard S
Corporate Controller
Transactions
- Award
Restricted Stock Units
2018-06-14+24,840→ 24,840 total→ Common Stock (24,840 underlying) - Award
Stock Option (right to buy)
2018-06-14+99,360→ 99,360 totalExercise: $2.04Exp: 2028-06-14→ Common Stock (99,360 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- [F3]The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0001458753
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:00 PM ET
- Size
- 8.3 KB